All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior consent of the JoongAng Ilbo | Tel: 1577-0510
JoongAng Ilbo Co., Ltd. | Address: 48-6 Sangamsan-ro, Mapo-gu, Seoul, Republic of Korea
Business registration number: 110-81-00999 | CEO & Publisher: Park Chang-hee | Executive Editor: Choi Ji-young
Mail order business report number: 2020-Seoul Mapo-3838 | Online newspaper registration No: 서울,아55177
Date of Registration: 2023. 11. 21 | Juvenile Protection Manager: Chun Young-sun
![Huons Global building in Gyeonggi [HUONS GLOBAL]](https://image.koreajoongangdaily.com/12576029.jpg?imageId=12576029&width=240&height=184&format=webp&format=jpg)
![Huons BioPharma delivers the first shipment of its botulinum toxin product, ‘Hutox,’ to the Chinese market. [HUONS BIOPHARMA]](https://image.koreajoongangdaily.com/12607744.jpg?imageId=12607744&width=240&height=184&format=webp&format=jpg)
![Huons BioPharma held a ground-breaking ceremony for its third production plant for Hutox botulinum toxin in Jecheon, North Chungcheong, on Tuesday. [JECHEON CITY OFFICE]](https://image.koreajoongangdaily.com/10385674.jpg?imageId=10385674&width=240&height=184&format=webp&format=jpg)
![Huons BioPharma logo [HUONS BIOPHARMA]](https://image.koreajoongangdaily.com/10180904.jpg?imageId=10180904&width=240&height=184&format=webp&format=jpg)
![Kim Yeong-mok, left, CEO of Huons BioPharma and Patrick Brenske, CEO of Haemato Pharm, pose for a photo after signing a supply deal on Monday at the Huons headquarters in Pangyo, Gyeonggi. [HUONS BIOPHARMA]](https://image.koreajoongangdaily.com/10174458.jpg?imageId=10174458&width=240&height=184&format=webp&format=jpg)